Eugene Rui

Person

San Diego, CA, US

People

Patents Grantslast 30 patents

Information Patent Grant
Modulators of STING (stimulator of interferon genes)
- Patent number 11,964,978
- Issue date Apr 23, 2024
- Pfizer Inc.
- Ketan Satish Gajiwala
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
CDK2/4/6 inhibitors
- Patent number 11,396,512
- Issue date Jul 26, 2022
- Pfizer Inc.
- Douglas Carl Behenna
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Anti-proliferative agents for treating PAH
- Patent number 11,203,594
- Issue date Dec 21, 2021
- Pfizer Inc.
- Samit Kumar Bhattacharya
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Cyclopentane-based modulators of STING (stimulator of interferon ge...
- Patent number 10,968,242
- Issue date Apr 6, 2021
- Pfizer Inc.
- Martin James Wythes
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
CDK2/4/6 inhibitors
- Patent number 10,800,783
- Issue date Oct 13, 2020
- Pfizer Inc.
- Douglas Carl Behenna
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Substituted carbonucleoside derivatives useful as anticancer agents
- Patent number 10,709,709
- Issue date Jul 14, 2020
- Pfizer Inc.
- John Howard Tatlock
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Cyclopentane-based modulators of STING (stimulator of interferon ge...
- Patent number 10,538,542
- Issue date Jan 21, 2020
- Pfizer Inc.
- Martin James Wythes
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Substituted nucleoside derivatives useful as anticancer agents
- Patent number 10,428,104
- Issue date Oct 1, 2019
- Pfizer Inc.
- John Howard Tatlock
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Aryl and heteroaryl fused lactams
- Patent number 10,246,433
- Issue date Apr 2, 2019
- Pfizer Inc.
- Martin Paul Edwards
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Substituted carbonucleoside derivatives useful as anticancer agents
- Patent number 10,220,037
- Issue date Mar 5, 2019
- Pfizer Inc.
- John Howard Tatlock
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Aryl and heteroaryl fused lactams
- Patent number 9,040,515
- Issue date May 26, 2015
- Pfizer Inc.
- Martin Paul Edwards
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Tricyclic compounds protein kinase inhibitors for enhancing the eff...
- Patent number 7,462,713
- Issue date Dec 9, 2008
- Agouron Pharmaceuticals, Inc.
- Suzanne Benedict
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Tricyclic compounds protein kinase inhibitors for enhancing the eff...
- Patent number 7,132,533
- Issue date Nov 7, 2006
- Agouron Pharmaceuticals, Inc.
- Suzanne Benedict
- C07 - ORGANIC CHEMISTRY

Patents Applicationslast 30 patents

Information Patent Application
MACROCYCLIC COMPOUNDS AND USE AS KINASE INHIBITORS
- Publication number 20250074920
- Publication date Mar 6, 2025
- BLOSSOMHILL THERAPEUTICS, INC.
- Jingrong Jean CUI
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Modulators of STING (Stimulator of Interferon Genes)
- Publication number 20240383903
- Publication date Nov 21, 2024
- Pfizer Inc.
- Ketan Satish GAJIWALA
- C07 - ORGANIC CHEMISTRY
Information Patent Application
MACROCYCLES AND THEIR USE
- Publication number 20240182487
- Publication date Jun 6, 2024
- BLOSSOMHILL THERAPEUTICS, INC.
- Jingrong J. CUI
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Cyclopentane-Based Modulators of STING (Stimulator of Interferon Ge...
- Publication number 20230382932
- Publication date Nov 30, 2023
- Pfizer Inc.
- Martin James Wythes
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
CDK2/4/6 Inhibitors
- Publication number 20220324872
- Publication date Oct 13, 2022
- Pfizer Inc.
- Douglas Carl Behenna
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Modulators of STING (Stimulator of Interferon Genes)
- Publication number 20220306641
- Publication date Sep 29, 2022
- Pfizer Inc.
- Ketan Satish GAJIWALA
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Cyclopentane-Based Modulators of STING (Stimulator of Interferon Ge...
- Publication number 20210230196
- Publication date Jul 29, 2021
- Pfizer Inc.
- Martin James Wythes
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Modulators of STING (Stimulator of Interferon Genes)
- Publication number 20210087180
- Publication date Mar 25, 2021
- Pfizer Inc.
- Ryan PATMAN
- C07 - ORGANIC CHEMISTRY
Information Patent Application
CDK2/4/6 Inhibitors
- Publication number 20200392142
- Publication date Dec 17, 2020
- Pfizer Inc.
- Douglas Carl Behenna
- C07 - ORGANIC CHEMISTRY
Information Patent Application
ANTI-PROLIFERATIVE AGENTS FOR TREATING PAH
- Publication number 20200331909
- Publication date Oct 22, 2020
- Pfizer Inc.
- Samit Kumar Bhattacharya
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Cyclopentane-Based Modulators of STING (Stimulator of Interferon Ge...
- Publication number 20200102334
- Publication date Apr 2, 2020
- Pfizer Inc.
- Martin James Wythes
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Cyclopentane-Based Modulators of STING (Stimulator of Interferon Ge...
- Publication number 20190284216
- Publication date Sep 19, 2019
- Pfizer Inc.
- Martin James Wythes
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
CDK2/4/6 Inhibitors
- Publication number 20190135817
- Publication date May 9, 2019
- Pfizer Inc.
- Douglas Carl Behenna
- C07 - ORGANIC CHEMISTRY
Information Patent Application
SUBSTITUTED CARBONUCLEOSIDE DERIVATIVES USEFUL AS ANTICANCER AGENTS
- Publication number 20190111060
- Publication date Apr 18, 2019
- Pfizer Inc.
- John Howard Tatlock
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
CDK2/4/6 Inhibitors
- Publication number 20180044344
- Publication date Feb 15, 2018
- Pfizer Inc.
- Douglas Carl Behenna
- C07 - ORGANIC CHEMISTRY
Information Patent Application
SUBSTITUTED CARBONUCLEOSIDE DERIVATIVES USEFUL AS ANTICANCER AGENTS
- Publication number 20170348313
- Publication date Dec 7, 2017
- Pfizer Inc.
- John Howard Tatlock
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ARYL AND HETEROARYL FUSED LACTAMS
- Publication number 20170233368
- Publication date Aug 17, 2017
- Pfizer Inc.
- Martin Paul EDWARDS
- C07 - ORGANIC CHEMISTRY
Information Patent Application
BENZAMIDE AND HETEROBENZAMIDE COMPOUNDS
- Publication number 20170152239
- Publication date Jun 1, 2017
- Pfizer Inc.
- Martin Paul Edwards
- C07 - ORGANIC CHEMISTRY
Information Patent Application
SUBSTITUTED NUCLEOSIDE DERIVATIVES USEFUL AS ANTICANCER AGENTS
- Publication number 20160244475
- Publication date Aug 25, 2016
- Pfizer Inc.
- John Howard Tatlock
- C07 - ORGANIC CHEMISTRY
Information Patent Application
BENZAMIDE AND HETEROBENZAMIDE COMPOUNDS
- Publication number 20150239842
- Publication date Aug 27, 2015
- Pfizer Inc.
- Martin Paul Edwards
- C07 - ORGANIC CHEMISTRY
Information Patent Application
ARYL AND HETEROARYL FUSED LACTAMS
- Publication number 20150175572
- Publication date Jun 25, 2015
- Pfizer Inc.
- Martin Paul EDWARDS
- C07 - ORGANIC CHEMISTRY
Information Patent Application
ARYL AND HETEROARYL FUSED LACTAMS
- Publication number 20140179667
- Publication date Jun 26, 2014
- Pfizer Inc.
- Martin Paul EDWARDS
- C07 - ORGANIC CHEMISTRY
Information Patent Application
HETEROCYCLES USEFUL AS INHIBITORS OF CARBONIC ANHYDRASE
- Publication number 20100256357
- Publication date Oct 7, 2010
- Agouron Pharmaceuticals, Inc.
- Wesley Kwan Mung Chong
- C07 - ORGANIC CHEMISTRY
Information Patent Application
TRICYCLIC COMPOUNDS PROTEIN KINASE INHIBITORS FOR ENHANCING THE EFF...
- Publication number 20070135415
- Publication date Jun 14, 2007
- Agouron Pharmaceuticals, Inc.
- Suzanne Benedict
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Tricyclic compounds protein kinase inhibitors for enhancing the eff...
- Publication number 20060004052
- Publication date Jan 5, 2006
- Agouron Pharmaceuticals, Inc.
- Suzanne Benedict
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Carbamate compositions and methods fo rmodulating the activity of t...
- Publication number 20050148643
- Publication date Jul 7, 2005
- Agouron Pharmaceuticals, Inc.
- Eugene Yuanjin Rui
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Person

Patents Grantslast 30 patents

Modulators of STING (stimulator of interferon genes)

CDK2/4/6 inhibitors

Anti-proliferative agents for treating PAH

Cyclopentane-based modulators of STING (stimulator of interferon ge...

CDK2/4/6 inhibitors

Substituted carbonucleoside derivatives useful as anticancer agents

Cyclopentane-based modulators of STING (stimulator of interferon ge...

Substituted nucleoside derivatives useful as anticancer agents

Aryl and heteroaryl fused lactams

Substituted carbonucleoside derivatives useful as anticancer agents

Aryl and heteroaryl fused lactams

Tricyclic compounds protein kinase inhibitors for enhancing the eff...

Tricyclic compounds protein kinase inhibitors for enhancing the eff...

Patents Applicationslast 30 patents

MACROCYCLIC COMPOUNDS AND USE AS KINASE INHIBITORS

Modulators of STING (Stimulator of Interferon Genes)

MACROCYCLES AND THEIR USE

Cyclopentane-Based Modulators of STING (Stimulator of Interferon Ge...

CDK2/4/6 Inhibitors

Modulators of STING (Stimulator of Interferon Genes)

Cyclopentane-Based Modulators of STING (Stimulator of Interferon Ge...

Modulators of STING (Stimulator of Interferon Genes)

CDK2/4/6 Inhibitors

ANTI-PROLIFERATIVE AGENTS FOR TREATING PAH

Cyclopentane-Based Modulators of STING (Stimulator of Interferon Ge...

Cyclopentane-Based Modulators of STING (Stimulator of Interferon Ge...

CDK2/4/6 Inhibitors

SUBSTITUTED CARBONUCLEOSIDE DERIVATIVES USEFUL AS ANTICANCER AGENTS

CDK2/4/6 Inhibitors

SUBSTITUTED CARBONUCLEOSIDE DERIVATIVES USEFUL AS ANTICANCER AGENTS

ARYL AND HETEROARYL FUSED LACTAMS

BENZAMIDE AND HETEROBENZAMIDE COMPOUNDS

SUBSTITUTED NUCLEOSIDE DERIVATIVES USEFUL AS ANTICANCER AGENTS

BENZAMIDE AND HETEROBENZAMIDE COMPOUNDS

ARYL AND HETEROARYL FUSED LACTAMS

ARYL AND HETEROARYL FUSED LACTAMS

HETEROCYCLES USEFUL AS INHIBITORS OF CARBONIC ANHYDRASE

TRICYCLIC COMPOUNDS PROTEIN KINASE INHIBITORS FOR ENHANCING THE EFF...

Tricyclic compounds protein kinase inhibitors for enhancing the eff...

Carbamate compositions and methods fo rmodulating the activity of t...